JoVE Logo
Faculty Resource Center

Sign In

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

DOI :

10.3791/54440-v

September 19th, 2016

September 19th, 2016

10,193 Views

1Department of Microbiology, University of Zaragoza

We herein detail the methodology followed to compare protective efficacy and lung immune response induced by intranasal and subcutaneous immunization with BCG in mouse model. Our results show the benefits of pulmonary vaccination and suggest a role for IL17-mediated response in vaccine-induced protection.

-- Views

Related Videos

article

In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol

article

Generating Genetically Modified Plasmodium berghei Sporozoites

article

Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis

article

Whole-Mount Fluorescence In Situ Hybridization to Study Spermatogenesis in the Anopheles Mosquito

article

Author Spotlight: Studying Host-Microbe Interactions in Wound Biofilm Formation

article

Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research

article

Author Spotlight: Neutrophil Extracellular Traps Imaging in Human and Mouse Tissues

article

Preparing Slides of CVS-11 Virus Antigen for Detecting Rabies-Specific Antibodies

article

Procedure for Swine Burn Wounding, Burn Wound Imaging, Wound Inoculation, and Biopsy Collection

article

Indirect Fluorescent Antibody (IFA) Test to Detect Rabies-Specific Antibody Isotypes in Sera or Cerebral Spinal Fluid

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved